Chemoradiotherapy vs. Radiotherapy Alone: New Insights from the BC2001 Trial for Muscle-Invasive Bladder Cancer

By Olivia Smith

Searching for the best way to treat bladder cancer, doctors are looking at using both chemotherapy and radiotherapy together. In this post, we talk about a study that looked at how well this combination works for people with muscle-invasive bladder cancer. Let’s explore what the study found and why it’s important…

Fight Bladder Cancer is delighted to share some of the recent advancements in therapeutic regimens for bladder cancer to improve patient outcomes. We would like to share one particular study which has focused on the long-term impact of combining chemotherapy and radiotherapy as a treatment regime for muscle-invasive bladder cancer in the Bladder Cancer 2001 (BC2001) phase 3 clinical trial.

This study aimed to compare the long-term outcomes of patients who had been treated with both chemotherapy (including 5-fluorouracil and mitomycin C) and radiotherapy in the BC2001 clinical trial to those treated with radiotherapy alone. This was particularly important to do so since data available on long-term recurrence risk is sparse. The radiotherapy and chemotherapy were administered over a period of 6.5 weeks. Interestingly, it was found in this study that of the 121 patients who were given both chemotherapy and radiotherapy concurrently, disease outcomes were significantly improved. For example, the 5-year tumour recurrence-free rate was 63% in those treated with both chemotherapy and radiotherapy. However, the 5-year tumour recurrence-free rate was only 49% in the 219 patients only treated with radiotherapy.

While the BC2001 trial offers promising insights into combining chemotherapy and radiotherapy for bladder cancer treatment, it’s essential to bear in mind some limitations of this research. The study involved a specific group of 340 patients, which may not represent everyone with this type of cancer. It focused on a particular combination of drugs, so results might vary with other treatments. While we saw the 5-year outcomes, potential long-term effects of the combined treatment might still emerge. It’s also possible that factors outside the trial, like peoples’ lifestyles or other health conditions, influenced the results. As with all research, it’s crucial to see this study as one piece of a bigger puzzle in understanding the best treatments for bladder cancer.

This study can be found at:

Hall, E., Hussain, S. A., Porta, N., Lewis, R., Crundwell, M., Jenkins, P., Rawlings, C., Tremlett, J., Sreenivasan, T., Wallace, J., Syndikus, I., Sheehan, D., Lydon, A., Huddart, R. and James, N. (2022) ‘Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial’, European urology, 82(3), pp. 273-279. https://www.sciencedirect.com/science/article/pii/S0302283822022655

What is a clinical trial?

A clinical trial is a type of research study that involves human participants. The aim of a clinical trial is to investigate various medical interventions within humans.

What is chemotherapy?

Chemotherapy is a type of drug used in medicine which has the aim of destroying cancer cells.

What is radiotherapy?

Radiotherapy is a type of cancer treatment which focuses on using radiation to kill cancer cells.

Conclusion

Bladder cancer treatment is continuously evolving, and recent studies shed light on new methods that can potentially enhance patient outcomes. Combining chemotherapy and radiotherapy, as shown in the BC2001 clinical trial, offers promising results for some particular type of people with muscle-invasive bladder cancer. It’s heartening to see the advances in treatments, and we remain committed to sharing the latest findings with our community.

Stay updated on the most recent developments in bladder cancer treatment. If you found this article informative, please share it with friends, family, and others who may benefit. Together, by raising awareness and supporting ongoing research, we can make a difference in the fight against bladder cancer. If you’d like to contribute or get involved with Fight Bladder Cancer, click here to learn how you can make an impact.

https://www.fightbladdercancer.co.uk/sites/default/files/downloads/FBCMuscle-Invasive-PIB-Digital.pdf